CG Oncology, Inc.

CGONNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$4.0M

▲ 254.7% YoY

Net Income

-$161.0M

▼ 82.9% YoY

EPS

$-2.08

▼ 47.5% YoY

Cash

$32.5M

▼ 87.4% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.